Growing evidence indicates that changes in cerebral BDNF levels and the BDNF-TrkB signaling pathway may be involved in the etiopathogenesis of AD and that serum and brain BDNF levels are correlated. The gene discussed is BDNF; the disease is Alzheimer disease.